Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
GEHC 
GE HealthCare Technologies Inc. (GEHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/04/2025: GEHC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
21 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $88.44
1 Year Target Price $88.44
| 12 | Strong Buy |
| 4 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -2.81% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/04/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 33.92B USD | Price to earnings Ratio 15.42 | 1Y Target Price 88.44 |
Price to earnings Ratio 15.42 | 1Y Target Price 88.44 | ||
Volume (30-day avg) 21 | Beta 1.28 | 52 Weeks Range 57.57 - 94.66 | Updated Date 11/4/2025 |
52 Weeks Range 57.57 - 94.66 | Updated Date 11/4/2025 | ||
Dividends yield (FY) 0.19% | Basic EPS (TTM) 4.83 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-29 | When Before Market | Estimate 1.04 | Actual 1.07 |
Profitability
Profit Margin 10.95% | Operating Margin (TTM) 14.21% |
Management Effectiveness
Return on Assets (TTM) 5.46% | Return on Equity (TTM) 24.45% |
Valuation
Trailing PE 15.42 | Forward PE 16.69 | Enterprise Value 42052095682 | Price to Sales(TTM) 1.68 |
Enterprise Value 42052095682 | Price to Sales(TTM) 1.68 | ||
Enterprise Value to Revenue 2.11 | Enterprise Value to EBITDA 11 | Shares Outstanding 455521592 | Shares Floating 454186914 |
Shares Outstanding 455521592 | Shares Floating 454186914 | ||
Percent Insiders 0.27 | Percent Institutions 88.6 |
Upturn AI SWOT
GE HealthCare Technologies Inc.
Company Overview
History and Background
GE HealthCare Technologies Inc. was spun off from General Electric in January 2023, becoming an independent publicly traded company. It builds on GE's 100+ year history in medical imaging, diagnostics, and patient care solutions.
Core Business Areas
- Imaging: Provides a broad portfolio of imaging technologies, including MRI, CT, X-ray, PET, and nuclear medicine systems. This includes sales, service, and installation.
- Ultrasound: Develops and manufactures ultrasound systems for various clinical applications, such as cardiology, radiology, and obstetrics/gynecology.
- Patient Care Solutions: Offers patient monitoring systems, anesthesia delivery systems, and other critical care equipment, along with related consumables and services.
- Pharmaceutical Diagnostics: Develops and manufactures contrast agents and radiopharmaceuticals used in medical imaging procedures to enhance image clarity and diagnostic accuracy.
Leadership and Structure
Peter Arduini serves as the President and CEO. The company has a traditional corporate structure with distinct business segments and functional departments, operating under a Board of Directors.
Top Products and Market Share
Key Offerings
- Competitors: Siemens Healthineers,Philips
- MRI Systems: Magnetic Resonance Imaging (MRI) systems used for detailed anatomical imaging. Competitors include Siemens Healthineers and Philips. No explicit market share or revenue data is publicly available for this specific product; but GE HealthCare is a leading player in the global MRI market.
- CT Scanners: Computed Tomography (CT) scanners used for cross-sectional imaging. Competitors include Siemens Healthineers and Philips. No explicit market share or revenue data is publicly available for this specific product; but GE HealthCare is a leading player in the global CT market.
- Competitors: Siemens Healthineers,Philips
- Competitors: Philips,Siemens Healthineers,Canon Medical Systems
- Ultrasound Systems: Diagnostic ultrasound machines. Competitors include Philips, Siemens Healthineers, Canon Medical Systems. No explicit market share or revenue data is publicly available for this specific product; but GE HealthCare is a leading player in the global Ultrasound market.
- Competitors: Bayer,Bracco Imaging
- Contrast Media: Contrast agents improve the visibility of internal structures on medical images. Competitors include Bayer and Bracco Imaging. No explicit market share or revenue data is publicly available for this specific product; but GE HealthCare is a leading player in the global Contrast Media market.
Market Dynamics
Industry Overview
The medical technology industry is driven by aging populations, increasing prevalence of chronic diseases, technological advancements, and growing demand for minimally invasive procedures. It's a highly regulated industry with significant R&D investments.
Positioning
GE HealthCare is a leading global provider of medical imaging, diagnostics, and patient care solutions. Its competitive advantages include its established brand reputation, broad product portfolio, global presence, and strong service network.
Total Addressable Market (TAM)
The global medical device market is expected to reach hundreds of billions of dollars. GE HealthCare is positioned to address a significant portion of this TAM through its diverse product lines and services.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive global presence
- Broad product portfolio
- Established service network
- Strong R&D capabilities
Weaknesses
- High debt levels post-spin-off
- Integration challenges from acquisitions
- Exposure to currency fluctuations
- Reliance on hospital capital spending
Opportunities
- Growth in emerging markets
- Increasing demand for advanced imaging technologies
- Expansion of digital health solutions
- Strategic partnerships and acquisitions
Threats
- Intense competition
- Pricing pressures
- Regulatory changes
- Technological obsolescence
- Economic downturns
Competitors and Market Share
Key Competitors
- SIEMENS (SIE.DE)
- PHILIPS (PHIA.AS)
- VARIAN MEDICAL SYSTEMS (Siemens Healthineers now owns Varian)
Competitive Landscape
GE HealthCare benefits from a strong brand and broad portfolio. Siemens Healthineers and Philips are formidable competitors with similar strengths. Competition is intense, with companies vying for market share through innovation, pricing, and service offerings.
Major Acquisitions
BK Medical
- Year: 2021
- Acquisition Price (USD millions): 1450
- Strategic Rationale: Expanded GE Healthcare's ultrasound portfolio and strengthened its position in surgical and point-of-care ultrasound.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited due to the recent spin-off. Analyzing past financial performance under GE's healthcare division can provide some insight.
Future Projections: Analyst estimates suggest potential for revenue growth driven by demand for medical imaging and diagnostics, particularly in emerging markets. Profitability is expected to improve as the company streamlines operations.
Recent Initiatives: Recent initiatives include investments in digital health solutions, strategic partnerships, and product innovation.
Summary
GE HealthCare is a leading medical technology company with a strong brand, broad product portfolio, and global presence. The spin-off presents both opportunities and challenges, including high debt levels and integration risks. Growth is expected to be driven by demand for medical imaging and diagnostics, particularly in emerging markets, but it faces stiff competition and regulatory hurdles. Strategic initiatives focused on digital health and acquisitions will be crucial to sustained success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry reports
- Market research reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Health Information Services | Full time employees 53000 | Website https://www.gehealthcare.com |
Full time employees 53000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.